Introducing the new AltIndexLearn more
4D Molecular Therapeutics

4D Molecular Therapeutics (FDMT) Earnings Prediction

Updated August 11, 2026 · AltIndex alt-data view going into the print

AltIndex AI Score on 4D Molecular Therapeutics is 49 — signals are mixed heading into the print.

Next report
Sunday, August 9, 2026
EPS Estimate
—
AltIndex AI Score
49
AI Prediction
Mixed signals

FDMT stock price — last 3 months

4D Molecular Therapeutics (FDMT) is trading at $11.47, up 16.4% over the last 3 months (from $9.85 three months ago).

What the alt-data signals say about 4D Molecular Therapeutics right now

Trends across the last 3 months — the run-up to 4D Molecular Therapeutics’s next earnings print.

Signal Current 3-month change
Job postings 13 No 3-month baseline
LinkedIn headcount 220 No 3-month baseline
Web traffic 14,357 No 3-month baseline

Full daily-resolution trend charts on every signal are on the FDMT ticker page.

Get alerted when FDMT signals inflect

AltIndex stock alerts fire when alt-data on FDMT breaks out — web traffic spike, hiring surge, sentiment shift — often days before the earnings number confirms it.

Sign up to AltIndex →

4D Molecular Therapeutics earnings: frequently asked questions

When does 4D Molecular Therapeutics report earnings next?
4D Molecular Therapeutics (FDMT) is scheduled to report next earnings on Sunday, August 9, 2026. The exact pre-market or post-market time is set by the company a few days ahead; see the official investor-relations page for confirmation.
What does the AltIndex AI Score say about 4D Molecular Therapeutics going into earnings?
Current AI Score on 4D Molecular Therapeutics: 49 — Mixed signals. The AI Score combines 10,000+ alternative-data and financial signals into one 0–100 number; higher = signals lean bullish, lower = signals lean bearish. Full per-signal breakdown is on the FDMT ticker page.
What is the EPS estimate for 4D Molecular Therapeutics?
EPS estimate for 4D Molecular Therapeutics’s next quarter isn’t available yet. We refresh estimates daily as analysts publish their numbers.
How accurate are AltIndex’s earnings predictions for 4D Molecular Therapeutics?
AltIndex doesn’t predict the exact EPS number — the alt-data signals don’t see the financials. What the signals can do is tell you whether the underlying business momentum (web traffic, hiring, social audience, sentiment) supports the analyst consensus or contradicts it. AltIndex publishes the full pick history at altindex.com/results — including the misses — so you can verify how the signal-driven calls have performed.
Where can I see the full signal breakdown on 4D Molecular Therapeutics?
Visit https://altindex.com/ticker/fdmt for the complete per-signal view: AI Score history, web traffic trend chart, 8-platform social audience tracking, hiring activity, news mention volume, sentiment scoring, insider trades and Congressional disclosures.
How can I get alerted before 4D Molecular Therapeutics reports earnings?
AltIndex stock alerts fire when alt-data signals on a stock break out of their historical range — often days or weeks before the earnings number confirms it. Add FDMT to your watchlist and you’ll get notified when its signals shift. See altindex.com/stock-alerts for the full alert categories.

Other earnings predictions

Other companies in the AltIndex universe reporting earnings in the next 2 weeks, sorted by AI Score.

← Back to the full earnings calendar

See every alt-data signal on FDMT

Sign up to see the full daily-resolution trend charts on every signal AltIndex tracks for 4D Molecular Therapeutics — web traffic, hiring, 8-platform social audience, sentiment, insider trades and the full AI Score breakdown.

Sign up to AltIndex → Log in
About AltIndex

Smarter investing with alternative data analytics and AI-powered insights.

Download on the App Store Get it on Google Play
Newsletter

AI stock picks and market insights, straight to your inbox.

Company
Features
More Data
© 2026 AltIndex. All rights reserved.